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Ethnopharmacological relevance: Schinus lentiscifolius Marchand (syn. Schinus weinmannifolius Engl) is a
plant native to Rio Grande do Sul (Southern Brazil) and has been used in Brazilian traditional medicine as
antiseptic and antimicrobial for the treatment of many different health problems as well as to treat
leucorrhea and to assist in ulcer and wound healing. Although it is a plant widely used by the population,
there are no studies proving this popular use.
Material and methods: The crude aqueous extract, the crude neutral methanol extract, fractions prepared
from this extract (n-hexane, ethyl acetate, and n-butanol), pure compounds isolated from these fractions,
and derivatives were investigated in vitro for antimicrobial activities against ﬁve Gram positive bacteria:
Bacillus subtilis, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus saprophyticus, Strepto-
coccus pyogenes, three Gram negative bacteria: Escherichia coli, Pseudomonas aeruginosa, and Shigella
sonnei, and four yeasts: Candida albicans, Candida tropicalis, Cryptococcus neoformans, and Saccharomyces
cerevisiae. The isolated compound moronic acid, which is the most active, was tested against a range of
other bacteria such as two Gram positive bacteria, namely, Bacillus cereus, Enterococcus spp, and six Gram
negative bacteria, namely, Burkholderia cepacia, Providencia stuartii, Morganella morganii, Enterobacter
cloacae, Enterobacter aerogenes, and Proteus mirabilis.
Results: The leaf aqueous extract (decoction) of Schinus lentiscifolius showed a broad spectrum of
antibacterial activity, ranging from 125 to 250 μg/ml (MIC) against the tested bacteria and fungi. The n-
hexane extract, despite being very little active against bacteria, showed an excellent antifungal activity,
especially against Candida albicans (MIC¼25 μg/ml), Candida tropicalis (MIC¼15.5 μg/ml), and Crypto-
coccus neoformans, (MIC¼15.5 μg/ml). From the acetate fraction (the most active against bacteria),
compounds 1–6 were isolated: nonadecanol (1), moronic acid (2), gallic acid methyl ester (3), gallic acid
(4), quercetin (5) and quercitrin (6). The minimal inhibitory concentration (MIC) of moronic acid between
1.5 and 3 μg/ml against most of the tested bacteria shows that it is one of the metabolites responsible for
the antibacterial activity of Schinus lentiscifolius.
Conclusion: The antimicrobial activity and some constituents of Schinus lentiscifolius are reported for the
ﬁrst time. The results of the present study provide scientiﬁc basis for the popular use of Schinus
lentiscifolius for a number of different health problems.
& 2013 Elsevier Ireland Ltd. All rights reserved.1. Introduction
The genus Schinus (Anacardiaceae) encompasses about 600
plant species typical of tropical and subtropical regions. The
species Schinus terebinthifolius Raddi, Schinus molle Hort. ex Engl.,
Schinus polygama (Cav.) Cabr., and Schinus lentiscifolius March are
native and common species in the forest of Rio Grande do Sul
(Biome Campos Sulinos, RS, Brazil), Uruguay, Paraguay, Argentinad Ltd. All rights reserved.
Maria (UFSM), Departamento
S, Brazil.
rel).and Peru. The ﬁrst three species above mentioned have been used
in South American folk medicine as antiseptic, antimicrobial and
repellent (Siddiqui et al., 1996; Wimalaratne et al., 1996; Guerra
et al., 2000; Ferrero et al., 2006, 2007; Lima et al., 2006; Deveci
et al., 2010; Santos et al., 2010) for the treatment of many different
health problems. Moreover, they have also been used to treat
leucorrhea, to heal ulcers and wounds (Bacchi, 1986; Fenner et al.,
2006), and to ﬁght uterine inﬂammation (Amorin and Santos,
2003), as well as analgesic and central depressant (Barrachina
et al., 1997). Previous phytochemical studies of this species have
resulted in the isolation of various sesquiterpenes, triterpenes,
ﬂavonoids, tannins, steroidal saponins, sterols, gums, resins and
essential oils (Yueqin et al., 2003; Erazo et al., 2006; Diaz et al., 2008).
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Schinus molle, it is often confused and used in folk medicine as
Schinus molle. Although little has been documented about the
popular use of Schinus lentiscifolius, the book Medicinal Plants in
Brazil (Lorenzi and Matos, 2002) mentions that the medicinal
application of Schinus lentiscifolius is the same as Schinus molle.
Phytochemical studies of Schinus molle have resulted in the
isolation of mono-sesqui and triterpenes, ﬂavonoids, gallotannins
and fatty acids (Hänsel et al., 1994), triterpeoidal ketoacids and
biﬂavone (Pozzo-Balbi et al., 1978; Yueqin et al., 2003), antioxidant
ﬂavonol glycosides (Marzouk et al., 2006), alkaloids, tannins, and
essential oils (Diaz et al., 2008). There are only few reports on the
chemical composition of the essential oil of the species Schinus
lentiscifolius (Rossini et al., 1996). Thus, due to lack of information
about the chemical components and activity of Schinus lentiscifo-
lius, the aim of this study was to describe the composition and the
antimicrobial activity of different extracts, fractions, and isolated
compounds from the leaves of this specie.2. Material and methods
2.1. Material and reagents
Melting points of the isolated compounds and derivatives were
determined with a “MQAPF-301” apparatus and are uncorrected.
Optical rotations were taken on a Perkin Elmer 341 digital
polarimeter. Low resolution ESI-MS was recorded on an Agilent
LC/MS/MS model 6460. 1H- and 13C-NMR spectra were recorded at
400.1/100.6 MHz on a Bruker DPX-400 spectrometer using CDCl3,
CD3OD and DMSO-d6 as solvent and TMS as internal standard.
Thin layer chromatography was performed on pre-coated TLC
plates (Merck, silica 60 F-254) by spraying with Liebermann–
Burchard's reagent and 10% H2SO4/EtOH, followed by heating.
2.2. Plant material, preparation of the extracts, and isolation
The aerial parts of Schinus lentiscifolius were collected in May
2010 in Ijui (latitude 28123'16" south and longitude 53154'53"
west), RS, Brazil, and authenticated by Prof Mara Lisiane Tissot
Squalli from the Department of Biology and Chemistry of the
University of Ijuí (DBQ-INIJUI) where a specimen sample (6.376) is
retained.
The dried aerial parts of Schinus lentiscifolius (400 g) was
powdered and extracted (300 g) four times with MeOH at room
temperature. The MeOH extract (ME) was ﬁltered and concen-
trated in vacuum to obtain a crude extract (50.1 g). Part of this
extract (40 g) was dissolved in H2O and extracted successively
with n-hexane (HF, 14 g), ethyl acetate (AF, 10 g) and n-butanol (BF,
8 g). A portion of the ethyl acetate fraction (5 g) was applied to
silica gel column (400 g) which was eluted with n-hexane contain-
ing increasing amounts of acetone (up to 100%) to give 20
fractions. Fractions 2–3 (n-hexane:acetone 99:1) were combined
to yield 1 (120 mg). Fractions 6 and 8 (n-hexane:acetone 90:10)
were combined (250 mg) and submitted to preparative TLC (n-
hexane:acetone 90:10, two elutions) to yield 2 (220 mg). Fraction
12 (n-hexane:acetone 70:30) was submitted to preparative TLC
(150 mg) (n-hexane:acetone 60:40, two elutions) to yield 4
(115 mg). Fraction 18 (n-hexane:acetone 30:70) was submitted to
preparative TLC (40 mg) (ethyl acetate: MeOH, 93:7, two elutions)
to yield 5 (16 mg). Fraction 21–22 (n-hexane:acetone 10:90) were
combined and evaporated to yield 3 (180 mg). Compounds 1,3–6
were identiﬁed by direct comparison (TLC, GC, and HPLC) with
authentic samples of nonadecanol (1), gallic acid methyl ester (3),
gallic acid (4), quercetin (5) and quercitrin (6). Identiﬁcation of
moronic acid (2) {mp 210–211 1C, ½α25D +50.2 (c 0.1, CHCl3)} wasmade by comparison of its spectral data (EIMS, 1H NMR and 13C
NMR, 1H-1H-COSY, DEPT 135, HMQC, and HMBC) with reported
values in the literature (Ito et al., 2001).
To prepare the aqueous extract (decoction), a portion of the dry
ground powder leaves (100 g) was extracted in distilled water
(boiled in water for 5 min) in the ratio 1:5(w/v). The resulting
solution was lyophilized into dry ﬁne powder yielding an aqueous
crude extract (16.4 g).
2.3. Preparation of the alcohol derivatives of moronic acid
The amount of 100 mg (0.209 mmol) of 2 was transferred to a
round-bottomed ﬂask and dissolved in 9 ml of absolute ethanol
(10 ml) and THF (2 ml). The mixture was then cooled in ice water
bath and added sodium borohydride (4 mg, 0.109 mmol). The
reaction was left to react for 12 h, and the solvent was evaporated.
Ice water was added, and the reaction was extracted three times
with ethyl acetate. Next, the organic layer was collected, dried
with Na2SO4, and evaporated. The resulting residue was chroma-
tographed on a silica gel column yielding two products with yields
of 60% and 20%, which were analyzed by NMR spectroscopy and
characterized as diastereoisomeric alcohol morolic acid (7) {mp
200–201 1C, ½α25D +29 (c 0.059, CHCl3)}, and acridocarpusic acid D
(8) {mp 242–244 1C, ½α25D +15.6 (c 0.1, MeOH)}. The identiﬁcation of
the compounds 7 and 8 was made by comparison of their spectral
data (EIMS, 1H NMR and 13C NMR, 1H- DEPT 135, HMQC, and
HMBC) with reported values in the literature (Ito et al., 2001; Cao
et al., 2004).
2.4. Preparation of moronic acid methyl ester
For methylations with diazomethane, 10 mg (0.02 mmol) of 2
was treated with an excess of ethereal diazomethane. After the
mixture had been kept at room temperature until the evolution of
nitrogen had ceased (about 30 min) the excess of diazomethane
and the ether were removed in vacuum yielding 9.8 mg of 9 {mp
168 1C, ½α25D +60 (c 0.1, CHCl3)}.
2.5. Antimicrobial activity
Compounds were also evaluated for their antimicrobial activity
against seven Gram positive bacteria: Bacillus cereus (ATCC 33019),
Bacillus subtilis (ATCC 6633), Enterococcus spp (ATCC 6589), Sta-
phylococcus aureus (ATCC 6538p), Staphylococcus epidermidis
(ATCC 12228), Streptococcus pyogenes (ATCC 19615), Staphylococcus
saprophyticus (ATCC 15305); nine Gram-negative bacteria: Bur-
kholderia cepacia (ATCC 17759), Enterobacter aerogenes (ATCC
13048), Enterobacter cloacae (ATCC 1304), Escherichia coli (ATCC
25922), Morganella morganii (ATCC 8019), Proteus mirabilis (ATCC
25933), Providencia stuartii (ITB 1971), Pseudomonas aeruginosa
(ATCC 17759), and Shigella sonnei (ATCC 15305), and three yeasts:
Candida albicans (ATCC 10231), Candida tropicalis (ATCC 750),
Cryptococcus neoformans (ATCC 208821), and Saccharomyes cerevi-
siae (ATCC 2601).
The minimal inhibitory concentration (MIC) was determined on
96-well culture plates by a micro dilution method using a micro-
organism suspension at a density of 105 CFU ml−1 with casein soy
broth incubated for 24 h at 37 1C for bacteria, and Sabouraud
Broth incubated for 48 h at 25 1C for yeasts. Cultures that did not
present growth were used to inoculate plates of solid medium
(Muller Hinton Agar and Sabouraud Agar) in order to determine
the minimal lethal concentration (MLC). Proper blanks were
assayed simultaneously and samples were tested in triplicate.
The reference antibiotics used were levoﬂoxacin, chloramphenicol
and ampicillin for bacteria, as well as nistatin for yeast
(Sigma). Technical data have been described previously
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2002a for yeast and National Committee for Clinical Laboratory
Standards, (NCCL), 2002b for bacteria).
2.6. Bacteriolytic activity
2.6.1. Bacteria and culture conditions
Bacterial cells were cultivated in casein soy broth (17 g of
enzymatic digest of casein, 3 g of enzymatic digest of soybean
meal, 2.5 g of dextrose, 5 g of sodium chloride, 2.5 g of dipotas-
sium phosphate per liter, pH 7.3) at 27 1C. The overnight bacterial
culture cells were harvested by centrifugation (10 min, 3000 rpm),
resuspended in fresh casein soy broth, and the number adjusted to
approximately 5107 cells per ml (OD600 nm∼0.2 with a SP-22
spectrophotometer, Biospectro, Brazil). Bacterial culture in broth,
solutions of antibiotics, and test samples were mixed in wells of a
96-well plate for optical density measurements.
2.6.2. Optical density (OD) measurements
Bacterial culture (180 μl) was added in a 96-well microplate.
The 96-well microplate was placed in a Spectra Max M2 micro-
plate spectrophotometer (Molecular Devices Corp.) programmed
to obtain measurements at 23 1C. Optical densities of cell cultures
were read using a 620 nm emission ﬁlter each 15 min with
shaking (30 s) between each reading measurement. Cells were
further cultivated to mid-logarithmic phase. Solutions of each test
samples and antibiotic (20 μl) at different concentrations in fresh
casein soy broth were added in a 96-well microplate. The 96-well
microplate was placed in a Spectra Max M2 and OD of cell cultures
containing test samples and antibiotic were read after 10 h of
incubation. Technical data have been described previously
(Lehtinen et al., 2006).
2.7. Statistical analysis
The effects of different concentrations of moronic acid and
ampicillin used as positive control on bacteria proliferation were
determined using one-way analysis of variance (ANOVA) repeated
measures followed by Bonferroni post hoc test. OD is presented asTable 1
Antibacterial activity of Schinus lentiscifolius: Extracts, fractions, isolated compounds an
Tested sample Microorganisms
Gram positive
Bacillus
subtilis
Staphylococcus
aureus
Staphylococcus
epidermidis
Streptoc
pyogene
MIC MLC MIC MLC MIC MLC MIC
H2O crude ext. 250 4500 125 4500 125 4500 125
MeOH crude ext. 250 4500 250 4500 500 4500 250
n-Hexane fraction 4500 4500 4500 4500 500 4500 4500
EtOAc fraction 125 4500 125 4500 250 4500 125
n-Butanol fraction 250 4500 250 4500 250 4500 250
Nonadecanol 50 4500 200 4200 200 4200 50
Moronic acid 1.52 25 1.52 25 100 4200 1.52
Morolic acid 100 4200 200 4200 100 4200 50
Moronic acid OMe 200 4200 200 4200 NT NT NT
Acridocarpusic acid D 100 4200 100 4200 100 4200 100
Quercetin 100 4200 100 4200 100 4200 100
Quercitrin 200 4200 200 4200 200 4200 200
Gallic acid 100 4200 100 4200 100 4200 100
Gallic acid OMe 4200 4500 4200 4500 4200 4500 4200
Levoﬂoxacin 1.52 1.52 1.52 1.52 1.52 1.52 1.52
Chloramphenicol 3.12 3.12 3.12 3.12 3.12 3.12 3.12
Ampicillin 10 NT 15 NT NT NT NT
MIC (minimum inhibitory concentration in μg/ml) and MLC (minimum lethal concentrapercent of control no treated group. A p value of less than 0.05 was
considered signiﬁcant. Analyses were carried out using the SPSS
statistical software, version 18.0 (SPSS Inc., Chicago, IL).3. Results and discussion
Results of the antimicrobial activity of the decoction, methanol
crude extract, fractions of this extract, isolated metabolites of
Schinus lentiscifolius, and moronic acid derivatives are summarized
in Tables 1–3. The leaf methanol crude extract of Schinus lentisci-
folius exhibited a signiﬁcant inhibitory activity against some of the
microorganisms tested. The methanol extract was partitioned
between water and n-hexane, ethyl acetate and n-butanol, respec-
tively. The n-hexane fraction showed an excellent antifungal
activity against the strains of the tested fungi. This activity is
possibly due to the content of volatile constituents of this fraction
(mono-and sesquiterpenes). The fraction ethyl acetate was the
most active against a panel of tested bacteria. A bioassay-guided
study of the ethyl acetate fraction led to the isolation and
identiﬁcation of nonadecanol (1), moronic acid (2), gallic acid
methyl ester (3), gallic acid (4), quercetin (5) and quercitrin (6).
Moronic acid (2) was previously isolated from Ozoa mucronata
(Hostettmann-Kaldas and Nakanishi, 1979), Rhus javanica
(Kurokawa et al., 1999) and from Brazilian propolis (Ito et al.,
2001); however, this is the ﬁrst report of the isolation of 2 from
Schinus sp. Although 2 is a known triterpene, its presence in a
medicinal plant is interesting because of the various biological
activities assigned to it, such as Anti-Herpes Simplex Virus
(Kurokawa et al., 1999), anti-tumor (Rios et al., 2001), anti-AIDS
agent, (Ito et al., 2001; Yu et al., 2006), anti-diabetic (Ramirez-
Espinosa et al., 2011), antimicrobial (Hostettmann-Kaldas and
Nakanishi, 1979), inhibition of the Epstein–Barr virus (Chang
et al., 2010), among others. In addition, 2 was subjected to a
stereoselective reduction of the carbonyl group to the correspond-
ing alcohol morolic acid (7) and acridocarpusic acid D (3-epi-
morolic acid, 8) in a 3:1 ratio (Fig. 1), both pentacyclic triterpenes
found naturally. Morolic acid was originally isolated from the
heart-wood of Mora exelsa (Barton and Brooks, 1950) andd derivatives (μg/ml).
Gram negative
occus
s
Staphylococcus
saprophyticus
Escherichia
coli
Pseudomonas
aeruginosa
Shigella sonnei
MLC MIC MLC MIC MLC MIC MLC MIC MLC
4500 125 4500 125 4500 250 4500 125 4500
4500 250 4500 500 4500 250 4500 4500 4500
4500 4500 4500 4500 4500 500 4500 4500 4500
4500 125 4500 250 4500 250 500 125 4500
4500 250 4500 250 4500 250 4500 250 500
4500 50 4500 200 4200 4200 4200 100 4200
25 1.52 25 3.12 25 100 4200 1.52 25
4200 50 4200 100 4200 100 4200 100 4200
NT 4200 4200 200 4200 100 4200 NT NT
4200 100 4200 100 4200 100 4200 100 4200
4200 100 4200 100 200 100 4200 100 4200
4200 200 4200 200 4200 200 4200 100 4200
4200 100 4200 100 4200 100 4200 100 4200
4500 4200 4500 4200 4500 4200 4500 4200 4500
1.52 1.52 1.52 1.52 1.52 1.52 6.25 1.52 1.52
3.12 3.12 3.12 3.12 3.12 3.12 3.12 3.12 3.12
NT NT NT 31 NT NT NT 31 NT
tion in μg/ml), NT (not tested).
Table 3
Antibacterial activity of moronic acid (μg/ml).
Compound Microorganisms
Gram positive Gram negative
Bacillus
cereus
Enterobacte
aerogenes
Enterococcus
spp
Burkholderia
cepacia
Enterobacter
cloacae
Morganella
morganii
Proteus
mirabilis
Providencia
stuartii
MIC MLC MIC MLC MIC MLC MIC MLC MIC MLC MIC MLC MIC MLC MIC MLC
Moronic acid 100 4200 100 4200 1.52 100 1.52 100 100 4200 200 4200 3.12 50 100 4200
Levoﬂoxacin 1.52 1.52 1.52 1.52 1.52 1.52 1.52 6.25 1.52 1.52 1.52 1.52 0.62 1.52 1.52 1.52
Chloramphenicol 3.12 3.12 3.12 3.12 3.12 3.12 3.12 3.12 3.12 3.12 3.12 3.12 3.12 3.12 3.12 3.12
Ampicilin NT NT NT NT 300 NT 300 NT NT NT NT NT NT NT NT NT
MIC (minimum inhibitory concentration in μg/ml) and MLC (minimum lethal concentration in μg/ml).
Table 2
Antifungal activity of Schinus lentiscifolius: extracts, fractions, isolated compounds and derivatives (μg/ml).
Tested sample Candida albicans Cryptococcus neoformans Candida tropicalis Saccharomyces cerevisiae
MIC MLC MIC MLC MIC MLC MIC MLC
H2O crude ext 250 250 250 250 125 250 250 500
MeOH crude ext 500 500 500 4500 500 4500 250 500
n-Hexane fraction 25 250 15.5 250 15.5 125 125 4500
EtOAc fraction 250 500 500 500 500 4500 500 500
n-Butanol fraction 500 4500 250 4500 125 4500 500 4500
Nonadecanol 200 4200 100 200 100 200 200 4200
Moronic acid 4200 4200 200 4200 4200 4200 200 200
Morolic acid 4200 4200 4200 4200 4200 4200 4200 4200
Moronic acid OMe 200 4200 50 200 100 200 200 4200
Acridocarpusic acid D 4200 4200 4200 4200 4200 4200 4200 4200
Quercetin 100 200 100 200 100 200 100 4100
Quercitrin 100 200 100 200 100 4200 200 4200
Gallic acid 200 200 100 200 100 200 100 4200
Gallic acid OMe 100 4200 100 4200 50 4200 125 4200
Nistatin 1.52 6.25 1.52 6.25 3.12 6.26 1.52 6.25
MIC (minimum inhibitory concentration in μg/ml) and MLC (minimum lethal concentration in μg/ml).
O
O
OH
(2)
NaBH4
EtOH,r.t
HO
O
OH
(8)
HO
O
OH
(7)
+
Moronic acid DdicacisupracodircAdicaciloroM
3:1
80%
Fig. 1. The reduction of moronic acid (2) in the presence of NaBH4 and ethanol to form morolic acid (7) and acridocarpusic acid D (8).
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vivy (Cao et al., 2004). Morolic acid and acridocarpusic acid D
exhibited important biological activities, such as anti-
inﬂammatory (Giner-Larza et al., 2002), anti-HIV and inhibitory
activity against glycogen phosphorylase (Zang et al., 2009). With
the aim of observing the importance of the carboxyl group in its
antimicrobial activity, moronic acid was converted into its methyl
ester (9) by treatment with diazomethane (–COOH-–COOMe).
Results of the antimicrobial activity in Table 1 show that moronic
acid (2), with a MIC of 1.52–3.12 μg/ml against most of the tested
bacteria, is the most active component of all isolates of Schinus
lentiscifolius. Compared to it, the three derivatives are less active
(MIC≥100 μg/ml), showing that the carbonyl and carboxyl func-
tions are important for its antimicrobial activity. The reduced
activity of 6 and 7 is in agreement with the results of Mendoza
et al. (1997) who found that increasing the hydrophilicity of
kaurene diterpenoids by the introduction of a 3-OH group theirantimicrobial activity reduced drastically. As shown in Table 2, the
isolated compounds and derivatives showed weak antifungal
activity (MIC≥100 μg/ml) against the tested fungal strains. Excep-
tions were the methylated derivatives of gallic and moronic acids,
which had their activities increased by the ester function. Moronic
acid OMe showed for instance an increased activity against
Cryptococcus neoformans (MIC¼50 μg/ml) compared to moronic
acid (MIC 4200 μg/ml), while the methyl gallate was twice as
active against Candida tropicalis (MIC¼50 μg/ml) as gallic acid
(MIC¼100 μg/ml). Comparing the activities of gallic and moronic
acids and their ester derivatives (Tables 1 and 2), it was observed
that the ester function decreased the antibacterial activity (parti-
cularly moronic acid) but increased the antifungal activity.
Because this plant is often used as tea, we also decided to
analyze the antimicrobial activity of this leaf aqueous extract
(decoction). The aqueous extract was prepared (boiled in water
for 5 min), lyophilized, and subjected to an antimicrobial screening
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crude aqueous extract exhibited a broad spectrum of antimicrobial
activity, ranging from 125 to 250 μg/ml against the tested bacteria
and fungi (Tables 1 and 2). The analysis of this extract shows the
presence of moronic acid (1) (GC, derivatization with diazo-
methane) and gallic acid methyl ester, gallic acid, quercetin and
quercitrin (analysis by HPLC), which could explain its activity.
According to the literature (Guerra et al., 2000; Amorin and
Santos, 2003; Lima et al., 2006; Deveci et al., 2010; Santos et al.,
2010), the essential oil and extracts of leaves of various species of
Schinus mainly Schinus molle and Schinus terebinthifolius have
clinically demonstrated antibacterial activity in vitro against sev-
eral strains of bacteria (which probably explains why it is used as
herbal remedy for different infectious diseases in their countries of
origin). These results encouraged us to test moronic acid, which is
the most active isolated compound against a range of other
bacteria, such as two Gram positive and six Gram negative bacteria
(see Table 3). Moronic acid shows excellent activity against
Enterococcus spp (MIC¼1.5 μg/ml), and against Burkholderia. cepa-
cia (MIC¼1.5 μg/ml), and Proteus mirabilis (MIC¼3.25 μg/ml).
None of the extracts, fractions and pure compounds were bater-Fig. 2. Staphylococcus aureus mean optical density (OD % of control) over 10 h for
Table 4
Bacteriolytic activity (%) of moronic acid and ampicillin against Gram positive (Bacillus s
Escherichia coli, Enterococcus spp, and Shigella sonnei).
Compound (μg/ml) Microorganisms
Gram positive Gram nega
Bacillus subtilis Staphylococcus aureus Burkholder
6 h 10 h 6 h 10 h 6 h
Moronic acid
2 20.073.3 30.471.0 32.5713.3 17.8712.0 27.270.6
4 24.371.8 27.577.2 68.770.9 72.972.5 27.471.0
8 29.174.8 33.271.8 71.570.7 73.072.1 23.272.0
16 26.377.3 30.374.7 68.071.1 69.178.8 23.170.6
33 27.375.7 30.675.2 62.073.5 65.073.4 24.671.8
Ampicillin
10 – – – – –
30 – – – – –
100 – – – – –
300 35.175.2 1.8710.5 – – –
1000 58.6710.8 54.9719.2 40.8713.4 56.977.1 –
–¼No activity was observed.icidal–fungicidal against the tested microorganisms (considering
MBC–MFC⪢4MIC). Kinetic measurement of the bacteriolytic
activities of moronic acid against the bacteria Enterococcus spp,
Bacillus subtilis, Staphylococcus aureus (Gram positive) and Escher-
ichia coli, Burkholderia cepacia and Shigella sonnei (Gram negative)
were determined by OD based on real time essay (Lehtinen et al.,
2006). Comparing the mode of action of moronic acid against the
selected bacteria, we suggest that its mechanism of action is
bacteriolytic with different intensities. Moronic acid signiﬁcantly
decreased the Staphylococcus aureus density from 2 h of exposition
at ≥2 μg/ml concetration (p¼0.0001). However, from ≥4 μg/ml the
density was 450% comparing to the treated control group. The
ampicillin showed effect on bacterial density just at higher
concentration (1000 μg/ml) from 4 h of exposition (p¼0.01)
(Fig. 2). As can be seen in Table 4, Burkholderia cepacia and Bacillus
subtilis presented susceptibility to moronic acid after 6 h of
exposition. At ≥2 μg/ml concentration we observed a decrease in
its density (p¼0.001). However, the density response was not
dependent on the moronic acid concentration and was around 20%
in relation to control. The ampicillin did not present effect on
Burkholderia cepacia density, whereas in Bacillus subtilis ≥300 μg/exposition to different concentrations of moronic acid (A) and ampicillin (B).
ubtilis and Staphylococcus aureus) and Gram negative bacteria (Burkholderia cepacia,
tive
ia cepacia Escherichia coli Enterococcus spp Shigella sonnei
10 h 6 h 10 h 6 h 10 h 6 h 10 h
33.170.9 – – – – – –
36.270.5 – – – – – –
30.971.6 – – – – – –
30.370.3 – – – – – –
37.774.9 5.571.1 6.471.0 – – 3.970.6 5.971.5
– – – – – 6.771.6 1.770.2
– – – – – – –
– – – – – 1.373.6 8.673.5
– 47.571.8 48.071.8 – – 0.970.8 1.371.2
– 48.271.7 51.871.8 – – 2.571.8 14.474.4
I.T.S. Gehrke et al. / Journal of Ethnopharmacology 148 (2013) 486–491 491ml decreased approximately 40% after 4 h of exposition. Moronic
acid presented no signiﬁcant bacteriolytic activity on Escherichia
coli and Shigella sonnei at the highest concentration tested (5.5–
6.6%). The ampicillin presented very little effect on Shigella sonnei
density, whereas in Escherichia coli ≥300 μg/ml decreased approxi-
mately 48% after 6 h of exposition. Neither moronic acid nor
ampicillin showed effect on Enterococcus spp density.4. Conclusion
This work provides new information about the antimicrobial
potential of Schinus lentiscifolius. Therefore, the results of the
present study provide scientiﬁc basis for the popular use of Schinus
lentiscifolius for a number of different health problems. It has been
used as antiseptic and antimicrobial as well as to treat leucorrhea,
to heal ulcers and wounds, to treat uterine inﬂammation and
urinary tract infections, and to relieve symptoms of rheumatoid
arthritis. Further experiments especially regarding toxicity of
Schinus lentiscifolius.are needed to prove the safety of the tradi-
tional preparations.Acknowledgments
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